Articles

Articles 89 records found  beginprevious16 - 25nextend  jump to record: Search took 0.00 seconds. 
16.
18 p, 30.1 MB Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells : Proof of Concept and Regulatory Compliance / Vives Armengol, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ; Hernández, Joaquim (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Mirabel, Clémentine (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Puigdomenech-poch, Maria (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Romeo-Guitart, David (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Marmolejo Martínez-Artesero, Sara (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Cabrera-Pérez, Raquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jaramillo, Jessica (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Kumru, Hatice (Universitat Autònoma de Barcelona. Departament de Medicina) ; García-lópez, Joan (Universitat Autònoma de Barcelona. Departament de Medicina) ; Vidal-Samsó, Joan (Universitat Autònoma de Barcelona. Departament de Medicina) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Coll-Bonet, Ruth (Banc de Sang i Teixits)
(1) Background: the use of Mesenchymal Stromal Cells (MSC) in emerging therapies for spinal cord injury (SCI) hold the potential to improve functional recovery. However, the development of cell-based medicines is challenging and preclinical studies addressing quality, safety and efficacy must be conducted prior to clinical testing; (2) Methods: herein we present (i) the characterization of the quality attributes of MSC from the Wharton's jelly (WJ) of the umbilical cord, (ii) safety of intrathecal infusion in a 3-month subchronic toxicity assessment study, and (iii) efficacy in a rat SCI model by controlled impaction (100 kdynes) after single (day 7 post-injury) and repeated dose of 1 × 10 MSC,WJ (days 7 and 14 post-injury) with 70-day monitoring by electrophysiological testing, motor function assessment and histology evaluation; (3) Results: no toxicity associated to MSC,WJ infusion was observed. [...]
2022 - 10.3390/cells11142153
Cells, Vol. 11 Núm. 14 (7-2 2022) , p. 2153  
17.
11 p, 1.5 MB New insights into peripheral nerve regeneration : The role of secretomes / Contreras, Estefania (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Bolívar Martín, Sara (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Udina i Bonet, Esther (Universitat Autònoma de Barcelona. Institut de Neurociències)
Neurons of the peripheral nervous system retain the intrinsic capability of regenerate their axons after injury, by triggering a complex activation response. This genetic switch is dependent of signals from the injured axon. [...]
2022 - 10.1016/j.expneurol.2022.114069
Experimental Neurology, Vol. 354 (august 2022) , p. 114069  
18.
17 p, 5.0 MB EST79232 and EST79376, Two novel sigma-1 receptor ligands, exert neuroprotection on models of motoneuron degeneration / Gaja Capdevila, Núria (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Hernández, Neus (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Yeste, Sandra (Parc Científic de Barcelona) ; Reinoso, Raquel (Parc Científic de Barcelona) ; Burgueño, Javier (Parc Científic de Barcelona) ; Montero, Ana (Parc Científic de Barcelona) ; Merlos, Manuel (Parc Científic de Barcelona) ; Vela, José M. (Parc Científic de Barcelona) ; Herrando-Grabulosa, Mireia (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Institut de Neurociències
Motor neuron diseases (MNDs) include sporadic and hereditary neurological disorders characterized by progressive degeneration of motor neurons (MNs). Sigma-1 receptor (Sig-1R) is a protein enriched in MNs, and mutations on its gene lead to various types of MND. [...]
2022 - 10.3390/ijms23126737
International journal of molecular sciences, Vol. 23, Issue 12 (June 2022) , art. 6737  
19.
16 p, 1.5 MB BET protein inhibition in macrophages enhances dorsal root ganglion neurite outgrowth in female mice / Palomés Borrajo, Georgina (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Penas Pérez, Clara (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Peripheral nerve regeneration is limited after injury, especially in humans, due to the large distance the axons have to grow in the limbs. This process is highly dependent on the expression of neuroinflammatory factors produced by macrophages and glial cells. [...]
2022 - 10.1002/jnr.25036
Journal of Neuroscience Research, Vol. 100 Núm. 6 (june 2022) , p. 1331-1346  
20.
2 p, 508.6 KB Editorial : Emerging Therapeutic Approaches for Repair and Regeneration of Injuries in the Peripheral Nervous System / Salgado, Antonio (University of Minho. School of Medicine) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Madduri, Srinivas (University of Geneva. Department of Surgery)
2022 - 10.3389/fbioe.2022.891459
Frontiers in Bioengineering and Biotechnology, Vol. 10 (March 2022) , art. 891459  
21.
28 p, 10.5 MB Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model / Alé, Albert (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Bruna, Jordi (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Morell, Marta (Universitat Autònoma de Barcelona. Institut de Neurociències) ; van de Velde, Helgi (Janssen Research and Development) ; Monbaliu, Johan (Janssen Research and Development) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Udina i Bonet, Esther (Universitat Autònoma de Barcelona. Institut de Neurociències)
Bortezomib (BTZ), a proteasome inhibitor, is an effective anti-neoplastic drug used in the treatment of multiple myeloma and mantle cell lymphoma. However, it can induce a reversible peripheral neuropathy that may lead to treatment discontinuation. [...]
2014 - 10.1016/j.expneurol.2013.12.020
Experimental Neurology, Vol. 253 (march 2014) , p. 165-173  
22.
29 p, 973.7 KB Schwann cells transduced with a lentiviral vector encoding Fgf-2 promote motor neuron regeneration following sciatic nerve injury / Allodi, Ilary (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Mecollari, Vasil (Netherlands Institute for Neurosciences) ; González-Pérez, Francisco (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Eggers, Ruben (Netherlands Institute for Neurosciences) ; Hoyng, Stefan (Netherlands Institute for Neurosciences) ; Verhaagen, Joost (Vrije Universiteit Amsterdam) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Udina i Bonet, Esther (Universitat Autònoma de Barcelona. Institut de Neurociències)
Fibroblast growth factor 2 (FGF-2) is a trophic factor expressed by glial cells and different neuronal populations. Addition of FGF-2 to spinal cord and dorsal root ganglia (DRG) explants demonstrated that FGF-2 specifically increases motor neuron axonal growth. [...]
2014 - 10.1002/glia.22712
GLIA, Vol. 62 (2014) , p. 1736-1746  
23.
43 p, 3.5 MB Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response / Calls, Aina (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Torres Espín, Abel (University of California) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Yuste, Victor J.. (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Udina i Bonet, Esther (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Bruna, Jordi (Universitat Autònoma de Barcelona. Institut de Neurociències)
Cisplatin-induced peripheral neuropathy (CIPN) is a frequent serious dose-dependent adverse event that can determine dosage limitations for cancer treatment. CIPN severity correlates with the amount of platinum detected in sensory neurons of the dorsal root ganglia (DRG). [...]
2020 - 10.1093/neuonc/noaa151
Neuro-Oncology, Vol. 23, Num. 1 (jan. 2021) , p. 88-99  
24.
14 p, 4.5 MB Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration / Cottilli, Patrick (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Gaja Capdevila, Núria (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Peripheral nerve injuries lead to the loss of motor, sensory and autonomic functions in the territories supplied by the injured nerve. Currently, nerve injuries are managed by surgical repair procedures, and there are no effective drugs in the clinic for improving the capacity of axonal regeneration. [...]
2022 - 10.3390/cells11071083
Cells, Vol. 11 Núm. 7 (2022) , art. 1083  
25.
16 p, 2.2 MB Transcutaneous electrical neuromodulation of the cervical spinal cord depends both on the stimulation intensity and the degree of voluntary activity for training. A pilot study / Kumru, Hatice (Institut Germans Trias i Pujol. Institut Guttmann) ; Rodríguez-Cañón, María (Institut Germans Trias i Pujol. Institut Guttmann) ; Edgerton, Victor (Institut Germans Trias i Pujol. Institut Guttmann) ; García, Loreto (Institut Germans Trias i Pujol. Institut Guttmann) ; Flores, África (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Soriano Crespo, Ignasi (Institut Germans Trias i Pujol. Institut Guttmann) ; Opisso, Eloy (Institut Germans Trias i Pujol. Institut Guttmann) ; Gerasimenko, Yury (University of Louisville) ; Navarro, X. (Xavier) (Institut Germans Trias i Pujol. Institut Guttmann) ; García Alias, Guillermo (Institut Germans Trias i Pujol. Institut Guttmann) ; Vidal, Joan (Institut Germans Trias i Pujol. Institut Guttmann)
Electrical enabling motor control (eEmc) through transcutaneous spinal cord stimulation offers promise in improving hand function. However, it is still unknown which stimulus intensity or which muscle force level could be better for this improvement. [...]
2021 - 10.3390/jcm10153278
Journal of clinical medicine, Vol. 10 Núm. 15 (january 2021) , p. 3278  

Articles : 89 records found   beginprevious16 - 25nextend  jump to record:
See also: similar author names
137 Navarro, X. (Xavier)
28 Navarro, X. (Xavier),
10 Navarro, Xavier
10 Navarro, Xavier
1 Navarro, Xavier.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.